Florida Tech Today: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Florida Tech Today.

Press releases published on September 24, 2026

Sep. 24, 2026

Boehringer Ingelheim and WHO Foundation launch global collaboration to close the gap in obesity and metabolic health

Indeterminate GlobeNewswire

Sep. 24, 2026

SL Science Presents Preclinical Data at the 85th Annual Meeting of the Japanese Cancer Association Showing γδ T Cells Target Chemotherapy-Resistant Glioblastoma

Indeterminate GlobeNewswire

Sep. 24, 2026

VisionWave Holdings Receives $20 Million Purchase Order for 200 STRATUM VARAN Unmanned Ground Vehicles, Subject to Conditions

Indeterminate GlobeNewswire

Sep. 24, 2026

Solenic Medical Appoints Daniel Hawkins as Chairman of the Board

Indeterminate GlobeNewswire

Sep. 24, 2026

Nearly 40% of Employees Don’t Know Which Skills Their Companies Will Need Next, New Research from Perceptyx Finds

Indeterminate GlobeNewswire

Sep. 24, 2026

Claris Bio Establishes Corporate Headquarters in San Francisco

Indeterminate GlobeNewswire

Sep. 24, 2026

BairesDev’s Rodrigo Outumuro Named to HR’s Rising Stars 2026

Indeterminate GlobeNewswire

Sep. 24, 2026

Cronos Hosts 2026 Investor Day

Indeterminate GlobeNewswire

Sep. 24, 2026

New Generation Consumer Group, Inc. (OTC: NGCG) Signs Letter of Intent for Proposed Strategic Business Combination with Nutrien Mineral Limited

Indeterminate GlobeNewswire

Sep. 24, 2026

Flux Launches New AI Capabilities to Take Hardware Designs From PCB to Prototype

Indeterminate GlobeNewswire

Sep. 24, 2026

Milestone Pharmaceuticals Enrolls First Canadian Study Participant in ReVeRA-301 Phase 3 Pivotal Trial Evaluating Etripamil Nasal Spray for AFib-RVR

Indeterminate GlobeNewswire

Sep. 24, 2026

Drug Developers Deploy In Silico Drug Safety Prediction Models From Deep Origin’s ARPA-H-Funded PREDICTS Consortium

Indeterminate GlobeNewswire

Sep. 24, 2026

Diginex Consolidates Group-Wide Expertise and Launches Sustainability Science & Intelligence Initiative to Accelerate Product Innovation and Drive Measurable Client Outcomes

Indeterminate GlobeNewswire

Sep. 24, 2026

Primmune Therapeutics Announces Enrollment Milestone in Phase 2 INFLECTION–003 Study of Polvitolimod HCl in Neoadjuvant Melanoma

Indeterminate GlobeNewswire

Sep. 24, 2026

Synack Expands Access to AI and Human Penetration Testing Across Cloud and Public Sector Marketplaces

Indeterminate GlobeNewswire

Sep. 24, 2026

Biolinq Shine™ Receives FDA 510(k) Clearance for Over-the-Counter Use

Indeterminate GlobeNewswire

Sep. 24, 2026

Liner Launches Liner Model API to Cut Enterprise LLM Costs by More Than 50%

Indeterminate GlobeNewswire

Sep. 24, 2026

Absci Announces Preliminary Details for Phase 2 STORYLINE™ Trial of AI-Designed Antibody ABS-201™ for Endometriosis

Indeterminate GlobeNewswire

Sep. 24, 2026

Elicio Therapeutics Announces Late-Breaking Phase 2 AMPLIFY-7P Data Selected for Proffered Paper Oral Presentation at ESMO Congress 2026

Indeterminate GlobeNewswire

Sep. 24, 2026

Precision Neuroscience Closes Oversubscribed $250M Series D Led by Pershing Square Inc., the Ackman Oxman Institute, and a Leading Life Sciences Investment Fund

Indeterminate GlobeNewswire